Rchr
J-GLOBAL ID:201801011320357438   Update date: Oct. 31, 2024

Mitsuyoshi Takamasa

ミツヨシ タカマサ | Mitsuyoshi Takamasa
Affiliation and department:
Research field  (2): Radiology ,  Tumor diagnostics and therapeutics
Research keywords  (6): 放射線治療 ,  SBRT ,  高精度放射線治療 ,  Lung cancer ,  脊椎SBRT ,  超寡分割全乳房照射
Research theme for competitive and other funds  (1):
  • 2019 - 2023 局所進行非小細胞肺癌に対するVMATを用いた新規照射法の確立
Papers (31):
  • Peter J K Tokuda, Takamasa Mitsuyoshi, Yuka Ono, Takahiro Kishi, Yoshiharu Negoro, Setsuko Okumura, Itaru Ikeda, Takashi Sakamoto, Yumi Kokubo, Ryo Ashida, et al. Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study. Breast cancer (Tokyo, Japan). 2024. 31. 4. 643-648
  • Yuta Sakurai, Shintaro Ambo, Mitsuhiro Nakamura, Hiraku Iramina, Yusuke Iizuka, Takamasa Mitsuyoshi, Yukinori Matsuo, Takashi Mizowaki. Development of a prediction model for target positioning by using diaphragm waveforms extracted from CBCT projection images. Journal of applied clinical medical physics. 2023. e14112
  • T. Iwai, T. Imagumbai, S. Hiraoka, T. Kishi, S. Okabayashi, R. Ashida, T. Mitsuyoshi, Y. Matsuo, T. Ishigaki, T. Mizowaki, et al. PO-1552 Scalp or face angiosarcoma treated with volumetric modulated arc therapy, a multicenter study. Radiotherapy and Oncology. 2023. 182. S1258-S1260
  • Takamasa Mitsuyoshi, Yuka Ono, Ryo Ashida, Mikiko Yamashita, Hiroaki Tanabe, Sayaka Takebe, Mariko Tokiwa, Eiji Suzuki, Toshiyuki Imagumbai, Michio Yoshimura, et al. Multi-institutional phase II study of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for breast cancer in Japan: Kyoto Radiation Oncology Study Group (UPBEAT study). Japanese journal of clinical oncology. 2022
  • Noriko Kishi, Yukinori Matsuo, Takashi Shintani, Masakazu Ogura, Takamasa Mitsuyoshi, Norio Araki, Kota Fujii, Setsuko Okumura, Kiyoshi Nakamatsu, Takahiro Kishi, et al. Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer. Journal of radiation research. 2022
more...
MISC (15):
  • 光吉 隆真, 芦田 良, 小野 幸果, 今葷倍 敏行, 吉村 通央, 山内 智香子, 溝脇 尚志, 小久保 雅樹. 乳房温存療法における超寡分割照射法の多機関共同非ランダム化検証的試験 第II相試験. 日本癌治療学会学術集会抄録集. 2022. 60回. O65-4
  • 光吉 隆真, 松尾 幸憲, 新谷 尭, 飯塚 裕介. 末梢性早期原発性肺癌に対する体幹部定位放射線治療の線量増加の治療成績. 肺癌. 2018. 58. 6. 517-517
  • 新谷 尭, 松尾 幸憲, 光吉 隆真, 飯塚 裕介. 心臓に近接したStage I期非小細胞肺癌に対する寡分割放射線治療は安全か?(Is Hypofractionated Radiotherapy Safe for Stage I Non-small Cell Lung Cancer in Proximity to Heart?). 肺癌. 2018. 58. 6. 628-628
  • Y. Iizuka, Y. Matsuo, T. Mitsuyoshi, T. Shintani, T. Mizowaki. Comparison of Target Delineation Methods in Dynamic Tumor Tracking Radiation Therapy for Lung Tumors Based on Internal Fiducial Markers. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2017. 99. 2. E672-E672
  • Y. Matsuo, T. F. Chen-Yoshikawa, M. Hamaji, T. Mitsuyoshi, T. Shintani, Y. Iizuka, M. Sonobe, H. Date, T. Mizowaki. Updated Results of Propensity-Based Analysis of Stereotactic Body Radiation Therapy and Sublobar Resection for Stage I Non-small Cell Lung Cancer in Patients at High Risk for Lobectomy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2017. 99. 2. E479-E479
more...
Education (1):
  • 2014 - 2018 京都大学大学院 医学研究科 放射線腫瘍学・画像応用治療学, 博士課程
Professional career (1):
  • MD, PhD (Kyoto University)
Work history (5):
  • 2024/03 - 現在 神戸市立医療センター中央市民病院 放射線治療科 医長
  • 2019/04 - 2024/03 神戸市立医療センター中央市民病院 放射線治療科 副医長
  • 2018/04 - 2019/03 京都大学医学部附属病院 放射線治療科 医員
  • 2012/04 - 2014/03 Osaka Prefectural Hospital Organization, Osaka Medical Center for Cancer and Cardiovascular Diseases
  • 2010/04 - 2012/03 名古屋セントラル病院 研修医
Committee career (1):
  • 2021/12 - 現在 日本肺癌学会 ガイドライン検討委員会 放射線治療及び集学的治療小委員会 委員
Association Membership(s) (4):
The Japan Lung Cancer Society ,  Japan Society of Clinical Oncology ,  JASTRO (Japanese Society for Radiation Oncology) ,  Japan Radiological Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page